APA (7th ed.) Citation

T, N., S, F., H, S., Y, I., H, T., M, K., & M, O. (2023). Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study. Lupus, 32(13), 1518. https://doi.org/10.1177/09612033231208845

Chicago Style (17th ed.) Citation

T, Nakai, Fukui S, Sawada H, Ikada Y, Tamaki H, Kishimoto M, and Okada M. "Disease-modifying Effect and Long-term Safety of Belimumab in Patients with Systemic Lupus Erythematosus: A Single-center Retrospective Study." Lupus 32, no. 13 (2023): 1518. https://doi.org/10.1177/09612033231208845.

MLA (9th ed.) Citation

T, Nakai, et al. "Disease-modifying Effect and Long-term Safety of Belimumab in Patients with Systemic Lupus Erythematosus: A Single-center Retrospective Study." Lupus, vol. 32, no. 13, 2023, p. 1518, https://doi.org/10.1177/09612033231208845.